ZA935076B - Quinoline and naphthyridine prodrugs - Google Patents
Quinoline and naphthyridine prodrugsInfo
- Publication number
- ZA935076B ZA935076B ZA935076A ZA935076A ZA935076B ZA 935076 B ZA935076 B ZA 935076B ZA 935076 A ZA935076 A ZA 935076A ZA 935076 A ZA935076 A ZA 935076A ZA 935076 B ZA935076 B ZA 935076B
- Authority
- ZA
- South Africa
- Prior art keywords
- naphthyridine
- prodrugs
- quinoline
- naphthyridine prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/914,188 US5235054A (en) | 1992-07-15 | 1992-07-15 | 3-carboxaldehyde substituted quinolines and naphthyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA935076B true ZA935076B (en) | 1995-01-16 |
Family
ID=25434020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA935076A ZA935076B (en) | 1992-07-15 | 1993-07-14 | Quinoline and naphthyridine prodrugs |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5235054A (xx) |
| EP (1) | EP0650488A1 (xx) |
| JP (1) | JPH07504684A (xx) |
| KR (1) | KR950702561A (xx) |
| CN (1) | CN1083053A (xx) |
| AU (1) | AU669958B2 (xx) |
| BR (1) | BR9306733A (xx) |
| CA (1) | CA2140135A1 (xx) |
| CZ (1) | CZ280603B6 (xx) |
| FI (1) | FI933203A (xx) |
| HU (1) | HUT68745A (xx) |
| IL (1) | IL106264A0 (xx) |
| MX (1) | MX9304266A (xx) |
| NO (1) | NO950142L (xx) |
| NZ (1) | NZ252847A (xx) |
| PL (1) | PL307135A1 (xx) |
| RU (1) | RU2097379C1 (xx) |
| SK (1) | SK4695A3 (xx) |
| WO (1) | WO1994002480A1 (xx) |
| ZA (1) | ZA935076B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378694A (en) * | 1990-09-07 | 1995-01-03 | Schering Corporation | Acyl and alkoxy substituted quinolines |
| EP0868183B1 (en) * | 1995-12-21 | 2002-01-30 | Pfizer Inc. | Injectable quinolone formulations |
| JO3077B1 (ar) * | 2005-07-28 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينولين مضادة للبكتيريا |
| EP2429991B1 (en) | 2009-05-15 | 2014-09-10 | Redx Pharma Limited | Redox drug derivatives |
| WO2020184578A1 (ja) * | 2019-03-11 | 2020-09-17 | 小胞体ストレス研究所株式会社 | 新規なｅＩＦ２αのリン酸化促進剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2509728A1 (fr) * | 1981-07-17 | 1983-01-21 | Roussel Uclaf | Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant |
| IN166416B (xx) * | 1985-09-18 | 1990-05-05 | Pfizer | |
| JP2777661B2 (ja) * | 1988-10-20 | 1998-07-23 | 大塚製薬株式会社 | ベンゾヘテロ環化合物 |
-
1992
- 1992-07-15 US US07/914,188 patent/US5235054A/en not_active Expired - Lifetime
-
1993
- 1993-04-23 WO PCT/US1993/003624 patent/WO1994002480A1/en not_active Application Discontinuation
- 1993-04-23 RU RU9595105159A patent/RU2097379C1/ru active
- 1993-04-23 JP JP6503987A patent/JPH07504684A/ja active Pending
- 1993-04-23 NZ NZ252847A patent/NZ252847A/en unknown
- 1993-04-23 EP EP93912293A patent/EP0650488A1/en not_active Withdrawn
- 1993-04-23 CA CA002140135A patent/CA2140135A1/en not_active Abandoned
- 1993-04-23 CZ CZ95101A patent/CZ280603B6/cs unknown
- 1993-04-23 BR BR9306733A patent/BR9306733A/pt not_active Application Discontinuation
- 1993-04-23 SK SK46-95A patent/SK4695A3/sk unknown
- 1993-04-23 AU AU55746/94A patent/AU669958B2/en not_active Ceased
- 1993-04-23 KR KR1019950700158A patent/KR950702561A/ko not_active Application Discontinuation
- 1993-04-23 PL PL93307135A patent/PL307135A1/xx unknown
- 1993-07-07 IL IL106264A patent/IL106264A0/xx unknown
- 1993-07-14 MX MX9304266A patent/MX9304266A/es not_active Application Discontinuation
- 1993-07-14 HU HU9302018A patent/HUT68745A/hu unknown
- 1993-07-14 ZA ZA935076A patent/ZA935076B/xx unknown
- 1993-07-14 CN CN93108457A patent/CN1083053A/zh active Pending
- 1993-07-14 FI FI933203A patent/FI933203A/fi unknown
-
1995
- 1995-01-13 NO NO950142A patent/NO950142L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL307135A1 (en) | 1995-05-02 |
| KR950702561A (ko) | 1995-07-29 |
| HUT68745A (en) | 1995-07-28 |
| NZ252847A (en) | 1996-07-26 |
| WO1994002480A1 (en) | 1994-02-03 |
| FI933203A0 (fi) | 1993-07-14 |
| NO950142D0 (no) | 1995-01-13 |
| AU669958B2 (en) | 1996-06-27 |
| NO950142L (no) | 1995-01-13 |
| SK4695A3 (en) | 1995-07-11 |
| US5235054A (en) | 1993-08-10 |
| RU2097379C1 (ru) | 1997-11-27 |
| CZ10195A3 (en) | 1995-09-13 |
| CA2140135A1 (en) | 1994-02-03 |
| FI933203A (fi) | 1994-01-16 |
| MX9304266A (es) | 1994-01-31 |
| HU9302018D0 (en) | 1993-10-28 |
| IL106264A0 (en) | 1993-11-15 |
| EP0650488A1 (en) | 1995-05-03 |
| RU95105159A (ru) | 1997-02-10 |
| JPH07504684A (ja) | 1995-05-25 |
| CN1083053A (zh) | 1994-03-02 |
| BR9306733A (pt) | 1999-01-12 |
| AU5574694A (en) | 1994-02-14 |
| CZ280603B6 (cs) | 1996-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9303601D0 (en) | Imidazopyridine | |
| AU115928S (en) | Pendant | |
| ZA937474B (en) | Quinolonecarboxylic acids | |
| ZA933274B (en) | Biphenylmethyl-subsituted pyridones | |
| ZA932459B (en) | Imidazopyridines | |
| GB2281170B (en) | Visual apparatus | |
| IL106264A0 (en) | Quinoline and naphthyridine prodrugs | |
| ZA933561B (en) | Quinoline derivatives and processes for preparing the same | |
| ZA937875B (en) | Imidazopyridines | |
| ZA93582B (en) | Substituted hexahyhdroazephinones and tetrahydrobenzazepinones | |
| GB2266707B (en) | Cases | |
| GB9201804D0 (en) | Methods | |
| GB9217116D0 (en) | Methods | |
| GB9201803D0 (en) | Methods | |
| GB2274507B (en) | Handlamps and torches | |
| AU120623S (en) | Caster plug | |
| ZA931368B (en) | Sulphonylbenzyl-substituted imidazopyridines | |
| GB2267396B (en) | Plug | |
| GB9205574D0 (en) | Swivel set square | |
| GB9223092D0 (en) | Interlocking device | |
| ZA936367B (en) | Esters | |
| GB9201427D0 (en) | Quinoline derivatives | |
| GB9214109D0 (en) | Lockable connector | |
| GB9218427D0 (en) | Plug | |
| PL294523A1 (en) | Plug |